U.S Physical Therapy Retained Earnings (Accumulated Deficit) 2010-2024 | USPH

U.S Physical Therapy retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
U.S Physical Therapy Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $224
2022 $233
2021 $224
2020 $212
2019 $184
2018 $167
2017 $162
2016 $150
2015 $138
2014 $134
2013 $119
2012 $111
2011 $102
2010 $90
2009 $76
U.S Physical Therapy Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-06-30 $226
2024-03-31 $224
2023-12-31 $224
2023-09-30 $239
2023-06-30 $238
2023-03-31 $235
2022-12-31 $233
2022-09-30 $236
2022-06-30 $232
2022-03-31 $227
2021-12-31 $224
2021-09-30 $219
2021-06-30 $216
2021-03-31 $210
2020-12-31 $212
2020-09-30 $203
2020-06-30 $195
2020-03-31 $183
2019-12-31 $184
2019-09-30 $181
2019-06-30 $177
2019-03-31 $169
2018-12-31 $167
2018-09-30 $165
2018-06-30 $166
2018-03-31 $163
2017-12-31 $162
2017-09-30 $158
2017-06-30 $155
2017-03-31 $153
2016-12-31 $150
2016-09-30 $161
2016-06-30 $157
2016-03-31 $152
2015-12-31 $138
2015-09-30 $145
2015-06-30 $141
2015-03-31 $136
2014-12-31 $134
2014-09-30 $131
2014-06-30 $127
2014-03-31 $122
2013-12-31 $119
2013-09-30 $117
2013-06-30 $118
2013-03-31 $114
2012-12-31 $111
2012-09-30 $113
2012-06-30 $110
2012-03-31 $106
2011-12-31 $102
2011-09-30 $98
2011-06-30 $97
2011-03-31 $93
2010-12-31 $90
2010-09-30 $86
2010-06-30 $83
2010-03-31 $79
2009-12-31 $76
2009-09-30 $79
2009-06-30 $76
2009-03-31 $72
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.428B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.039B 12.12
Quest Diagnostics (DGX) United States $17.877B 18.12
DaVita (DVA) United States $12.667B 16.38
Encompass Health (EHC) United States $10.405B 24.53
Chemed (CHE) United States $8.459B 26.00
Elanco Animal Health (ELAN) United States $7.054B 16.79
RadNet (RDNT) United States $6.388B 141.61
Option Care Health (OPCH) United States $3.890B 18.43
Amedisys (AMED) United States $3.035B 21.60
LifeStance Health (LFST) United States $2.828B 0.00
Addus HomeCare (ADUS) United States $2.320B 27.22
Astrana Health (ASTH) United States $2.297B 36.01
Pennant (PNTG) United States $1.162B 46.99
Aveanna Healthcare Holdings (AVAH) United States $1.149B 0.00
Atai Life Sciences (ATAI) Germany $0.265B 0.00
Daxor (DXR) United States $0.042B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00